Newsfiscal.ai
Lineage Cell Therapeutics Provides Update on ReSonance Program for Hearing Loss
· Published
Article summary
Lineage Cell Therapeutics has provided a progress update on its ReSonance (ANP1) cell transplant program for hearing loss, which is being developed under a research collaboration.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…